Evidence map›Paper›PMID 40098951›Full record

ArticleFrontiers in immunology2025

Transkingdom mechanism of MAMP generation by chitotriosidase feeds oligomeric chitin from fungal pathogens and allergens into TLR2-mediated innate immune sensing.

Tzu-Hsuan Chang, Yamel Cardona Gloria, Margareta J Hellmann, Timmy Richardo, Carsten Leo Greve, Didier Le Roy, Thierry Roger, Francesca Bork, Stefanie Bugl, Johanna Jakob and 9 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Acetylation and accessibility ofCell surface (Amsterdam, Netherlands) · 2026
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Tzu-Hsuan ChangDepartment of Innate Immunity, Institute of Immunology, University of Tübingen, Tübingen, Germany.
Yamel Cardona GloriaDepartment of Innate Immunity, Institute of Immunology, University of Tübingen, Tübingen, Germany.
Margareta J HellmannInstitute for Biology and Biotechnology of Plants, University of Münster, Münster, Germany.
Timmy RichardoDepartment of Innate Immunity, Institute of Immunology, University of Tübingen, Tübingen, Germany.
Carsten Leo GreveDepartment of Innate Immunity, Institute of Immunology, University of Tübingen, Tübingen, Germany.
Didier Le RoyInfectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Thierry RogerInfectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Francesca BorkDepartment of Innate Immunity, Institute of Immunology, University of Tübingen, Tübingen, Germany.
Stefanie BuglDepartment of Innate Immunity, Institute of Immunology, University of Tübingen, Tübingen, Germany.
Johanna JakobDepartment of Innate Immunity, Institute of Immunology, University of Tübingen, Tübingen, Germany.
Johannes SonnbergerDepartment of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.
Lydia KasperDepartment of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.
Bernhard HubeDepartment of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.
Stefan PuschDepartment of Neuropathology, Institute of Pathology, Ruprecht-Karls-University Heidelberg and German Cancer Consortium (DKTK), Clinical Cooperation Unit (CCU) Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Neil A R GowDepartment of Biosciences, Medical Research Council Centre for Medical Mycology at The University of Exeter, University of Exeter, Exeter, United Kingdom.
Morten SørlieDepartment of Chemistry, Biotechnology, and Food Science, Norwegian University of Life Sciences, Ås, Norway.
Anne TøndervikDepartment of Biotechnology and Nanomedicine, Stiftelsen for Industriell og Teknisk Forskning (SINTEF) Industry, Trondheim, Norway.
Bruno M MoerschbacherInstitute for Biology and Biotechnology of Plants, University of Münster, Münster, Germany.
Alexander N R WeberDepartment of Innate Immunity, Institute of Immunology, University of Tübingen, Tübingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Chitin is a highly abundant polysaccharide in nature and is linked to immune recognition of fungal infections and asthma in humans. Ubiquitous in fungi and insects, chitin is absent inmammals and plants and, thus, represents a microbeassociatedmolecular pattern (MAMP). However, highly polymeric chitin is insoluble, which potentially hampers recognition by host immune sensors. In plants, secreted chitinases degrade polymeric chitin into diffusible oligomers, which are "fed to" innate immune receptors and co-receptors. In human and murine immune cells, a similar enzymatic activity was shown for human chitotriosidase (CHIT1), and oligomeric chitin is sensed via an innate immune receptor, Toll-like receptor (TLR) 2. However, a complete system of generating MAMPs from chitin and feeding them into a specific receptor/co-receptor-aided sensing mechanism has remained unknown in mammals. Methods: The effect of the secreted chitinolytic host enzyme, CHIT1, on the TLR2 activity of polymeric chitin preparations from shrimps, house dust mites and the fungal pathogen Candida albicans was assessed in vitro using cell lines and primary immune cells. Moreover, the regulation of CHIT1 was analyzed. Results: Here, we show that CHIT1 converts inert polymeric chitin into diffusible oligomers that can be sensed by TLR1/TLR2 co-receptor/receptor heterodimers, a process promoted by the lipopolysaccharide binding protein (LBP) and CD14. Furthermore, we observed that Discussion: Our study shows the existence of an inducible system of MAMP generation in the human host that enables contact-independent immune activation by diffusible MAMP ligands with a striking similarity to the plant kingdom. Moreover, this study highlights CHIT1 as a potential therapeutic target for TLR2-mediated inflammatory processes that are fueled by oligomeric chitin.

Indexed as

AllergensCandida albicansChitinHexosaminidasesImmunity, InnatePathogen-Associated Molecular Pattern MoleculesToll-Like Receptor 2AnimalsHumansMiceAllergensChitinchitotriosidaseHexosaminidasesPathogen-Associated Molecular Pattern MoleculesTLR2 protein, humanToll-Like Receptor 2Candida albicanschitinchitotriosidaseinflammationinnate immunitymyeloid cellN-acetyl-glucosamineToll-like receptor (TLR)

Identifiers

PMID40098951
PMCPMC11911531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.